Article Text

Download PDFPDF
Systematic review
Patients who self-monitor or self-manage can improve the quality of their oral anticoagulation therapy
  1. Michelle Kennedy
  1. Faculty of Health and Social Care, University of Hull, Hull, UK
  1. Correspondence to: Michelle Kennedy, Faculty of Health and Social Care, University of Hull, Aire Building, Cottingham Road, Hull HU6 7RX, UK; M.L.Kennedy{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Commentary on: OpenUrl

Implications for practice and research

  • For suitable patients self-monitoring or self-managing enhances the quality of oral anticoagulation therapy.

  • Self-monitoring and self-managing patients experience greater time in therapeutic range with the associated decrease in thromboembolic events.

  • Future research should focus on establishing the factors affecting the uptake of self-monitoring and self-managing of oral anticoagulation.


There are 950 000 people in the UK taking oral anticoagulants in the form of vitamin K antagonists such as warfarin1 for prevention of thromboembolic events associated with conditions including atrial fibrillation (AF) and prosthetic heart valves. With the current ongoing rise in AF diagnosis, this number has the potential to rise further.

Vitamin K antagonists have a narrow therapeutic window and in order to maintain the effectiveness …

View Full Text


  • Competing interests None declared.

  • Provenance and peer review Commissioned; internally peer reviewed.